At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
In Brief
A clinical study evaluating Symplicity Spyral™ multi-electrode renal denervation system and Sham Procedure for Hypertension and 2 related conditions. Completed, enrolled 337 participants across 56 sites in 10 countries.
Signals
Detailed Summary
The purpose of this study is to test the hypothesis that renal denervation decreases blood pressure and is safe when studied in the presence of up to three standard antihypertensive medications.
Study Details
Timeline
Arms & Interventions
Renal angiography and Renal Denervation (Symplicity Spyral™ multi-electrode renal denervation system)
Renal angiography
Interventions
After a renal angiography according to standard procedures, subjects remain blinded and are immediately treated with the renal denervation procedure after randomization.
After a renal angiography according to standard procedures, subjects remain blinded and remain on the catheterization lab table for at least 20 minutes prior to introducer sheath removal.